Mutations of METTL3 predict response to neoadjuvant chemotherapy in muscle-invasive bladder cancer

BACKGROUND AND AIM: Neoadjuvant chemotherapy (NAC) followed by radical cystectomy is the current gold standard treatment for muscle-invasive urothelial bladder cancer (MIBC). Nonetheless, some MIBC patients showed limited pathological response after NAC. Herein, we used whole-exome sequencing (WES)...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Transl Res
Main Authors: Yang, Zhao, Shen, Zongyi, Jin, Di, Zhang, Nan, Wang, Yue, Lei, Wanjun, Zhang, Zhiming, Chen, Haige, Naz, Faiza, Xu, Lida, Wang, Lei, Wang, Shihui, Su, Xin, Yu, Changyuan, Li, Chong
Formato: Artigo
Idioma:Inglês
Publicado: Whioce Publishing Pte. Ltd. 2021
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8259609/
https://ncbi.nlm.nih.gov/pubmed/34239995
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares